Masood Hassan, Burki Ahmed M, Sultan Anum, Sharif Hina, Ghauri Asim, Khan Sehrish, Qureshi Muhammad Shoaib Safdar, Qadeer Aayesha, Rasheed Ghulam
Internal Medicine, Shifa International Hospital, Islamabad, PAK.
Anesthesiology and Critical Care, Combined Military Hospital, Rawalpindi, PAK.
Cureus. 2019 Jun 27;11(6):e5016. doi: 10.7759/cureus.5016.
The aim of this study was to assess the efficacy of intravenous vitamin C, hydrocortisone, and thiamine in early weaning (within 48 hours) from vasopressor support in patients with septic shock. We also aimed to assess mortality and intensive care unit (ICU) stay.
We conducted a descriptive case series study of 50 patients with septic shock who were admitted in the ICU of the Combined Military Hospital Rawalpindi in Pakistan from August 2017 until April 2018.
The study included men and women (16 to 80 years of age) who were admitted to the ICU with septic shock. Data were analysed using the IBM Statistical Package for Social Sciences (SPSS), version 18.0 (IBM Corp., Armonk, NY, USA). Inferential analysis was done with the help of simple and multivariate binary logistic regression that generated unadjusted and adjusted odds ratios (OR), respectively.
Of the 50 patients, 56% (N = 28) were male with a mean age of the respondents being 46.7 ± 18.4. Eighty-four percent were successfully weaned off vasopressors within 48 hours. Median days in the ICU were reported as 8.3 (interquartile range (IQR) = 5). Primary bacteremia (34%) was the most reported cause of ICU admission. The most common vasopressor was norepinephrine and its mean dose was 21.6 ± 10.7 microgram/min. The ICU mortality was observed at 52% (N = 26). Unadjusted OR showed a dose of norepinephrine, Sequential Organ Failure Assessment (SOFA) score, plasma procalcitonin, and plasma lactate to be significant predictors (p-value < 0.05), while the adjusted odds ratio (AOR) showed only a dose of norepinephrine to be a statistically significant predictor (AOR = 0.804, 95% CI = 0.674 - 0.960; p-value = 0.016).
The administration of intravenous vitamin C, hydrocortisone, and thiamine to patients with septic shock was successful in early weaning from vasopressors. There was also a reduction in procalcitonin and lactate levels, as well as the SOFA score. Further trials are needed to determine whether the metabolic resuscitation protocol can become part of the treatment for septic shock.
本研究旨在评估静脉注射维生素C、氢化可的松和硫胺素对感染性休克患者在48小时内早期停用血管升压药的疗效。我们还旨在评估死亡率和重症监护病房(ICU)住院时间。
我们对2017年8月至2018年4月在巴基斯坦拉瓦尔品第联合军事医院ICU住院的50例感染性休克患者进行了描述性病例系列研究。
该研究纳入了因感染性休克入住ICU的男性和女性(年龄在16至80岁之间)。数据使用IBM社会科学统计软件包(SPSS)18.0版(美国纽约州阿蒙克市IBM公司)进行分析。推断性分析借助简单和多变量二元逻辑回归进行,分别生成未调整和调整后的比值比(OR)。
50例患者中,56%(N = 28)为男性,受访者的平均年龄为46.7±18.4岁。84%的患者在48小时内成功停用血管升压药。报告的ICU中位住院天数为8.3天(四分位间距(IQR)= 5)。原发性菌血症(34%)是最常报告的入住ICU原因。最常用的血管升压药是去甲肾上腺素,其平均剂量为21.6±10.7微克/分钟。观察到ICU死亡率为52%(N = 26)。未调整的OR显示去甲肾上腺素剂量、序贯器官衰竭评估(SOFA)评分、血浆降钙素原和血浆乳酸是显著预测因素(p值<0.05),而调整后的比值比(AOR)显示只有去甲肾上腺素剂量是具有统计学意义的预测因素(AOR = 0.804,95%置信区间 = 0.674 - 0.960;p值 = 0.016)。
对感染性休克患者静脉注射维生素C、氢化可的松和硫胺素成功实现了早期停用血管升压药。降钙素原和乳酸水平以及SOFA评分也有所降低。需要进一步试验来确定代谢复苏方案是否能成为感染性休克治疗的一部分。